F Dx Advisors, Inc. Astrazeneca PLC Transaction History

F Dx Advisors, Inc.

$367 Million
Q3 2024

A detailed history of F Dx Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, F Dx Advisors, Inc. holds 12,053 shares of AZN stock, worth $798,270. This represents 0.26% of its overall portfolio holdings.

Number of Shares

12,053

Previous 12,562 4.05%

Holding current value

$798,270

Previous $980,000 4.18%

% of portfolio

0.26%

Previous 0.27%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$76.67 - $87.62 $39,025 - $44,598	-509 Reduced 4.05%	12,053 $939,000
Q2 2024 Aug 02, 2024	SELL	$66.81 - $80.83 $403,799 - $488,536	-6,044 Reduced 32.48%	12,562 $980,000
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $467,917 - $533,393	-7,667 Reduced 29.18%	18,606 $1.26 Million
Q4 2023 Feb 12, 2024	SELL	$61.89 - $69.28 $45,055 - $50,435	-728 Reduced 2.7%	26,273 $1.77 Million
Q3 2023 Nov 02, 2023	SELL	$64.85 - $71.7 $274,250 - $303,219	-4,229 Reduced 13.54%	27,001 $1.83 Million
Q2 2023 Jul 17, 2023	BUY	$69.91 - $75.81 $245,034 - $265,714	3,505 Added 12.64%	31,230 $2.24 Million
Q4 2022 Feb 09, 2023	SELL	$54.21 - $70.44 $190,222 - $247,173	-3,509 Reduced 11.23%	27,725 $1.88 Million
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $118,022 - $302,179	-2,226 Reduced 6.65%	31,234 $1.71 Million
Q2 2022 Aug 03, 2022	BUY	$59.26 - $71.14 $1.98 Million - $2.38 Million	33,460 New	33,460 $2.21 Million
Q1 2022 May 03, 2022	SELL	$55.72 - $67.12 $2.87 Million - $3.45 Million	-51,459 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$54.02 - $63.83 $167,462 - $197,873	-3,100 Reduced 5.68%	51,459 $3 Million
Q3 2021 Oct 08, 2021	SELL	$55.56 - $60.79 $7,778 - $8,510	-140 Reduced 0.26%	54,559 $3.28 Million
Q2 2021 Aug 05, 2021	BUY	$48.42 - $60.18 $560,606 - $696,764	11,578 Added 26.85%	54,699 $3.28 Million
Q1 2021 Apr 14, 2021	BUY	$47.16 - $54.44 $1.93 Million - $2.23 Million	40,977 Added 1911.24%	43,121 $2.14 Million
Q1 2021 Apr 13, 2021	SELL	$47.16 - $54.44 $2.51 Million - $2.9 Million	-53,267 Reduced 96.13%	2,144 $106,000
Q4 2020 Feb 08, 2021	SELL	$48.52 - $58.02 $227,995 - $272,635	-4,699 Reduced 7.82%	55,411 $2.77 Million
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $260,892 - $300,367	-4,916 Reduced 7.56%	60,110 $3.29 Million
Q2 2020 Jul 22, 2020	BUY	$43.1 - $55.31 $270,754 - $347,457	6,282 Added 10.69%	65,026 $3.44 Million
Q1 2020 May 22, 2020	BUY	$37.79 - $51.33 $2.22 Million - $3.02 Million	58,744 New	58,744 $2.62 Million
Q1 2020 May 13, 2020	SELL	$37.79 - $51.33 $1.58 Million - $2.15 Million	-41,859 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$42.46 - $50.46 $163,640 - $194,472	-3,854 Reduced 8.43%	41,859 $2.09 Million
Q3 2019 Nov 07, 2019	BUY	$40.12 - $45.47 $39,237 - $44,469	978 Added 2.19%	45,713 $2.04 Million
Q2 2019 Jul 19, 2019	BUY	$37.28 - $41.68 $1.08 Million - $1.2 Million	28,896 Added 182.44%	44,735 $1.85 Million
Q1 2019 May 14, 2019	SELL	$35.49 - $43.02 $226,710 - $274,811	-6,388 Reduced 28.74%	15,839 $640,000
Q4 2018 Apr 29, 2019	SELL	$36.86 - $41.49 $76,779 - $86,423	-2,083 Reduced 8.57%	22,227 $844,000
Q4 2018 Feb 07, 2019	SELL	$36.86 - $41.49 $873,397 - $983,105	-23,695 Reduced 49.36%	24,310 $923,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $1.16 Million - $1.33 Million	-33,418 Reduced 41.04%	48,005 $1.9 Million
Q2 2018 Aug 08, 2018	SELL	$34.55 - $37.05 $304,696 - $326,743	-8,819 Reduced 9.77%	81,423 $2.86 Million
Q1 2018 May 02, 2018	SELL	$32.97 - $36.63 $2.18 Million - $2.42 Million	-66,080 Reduced 42.27%	90,242 $3.16 Million
Q4 2017 Feb 09, 2018	BUY	$32.09 - $34.78 $404,975 - $438,923	12,620 Added 8.78%	156,322 $5.42 Million
Q3 2017 Nov 03, 2017	BUY	$28.96 - $34.0 $748,268 - $878,492	25,838 Added 21.92%	143,702 $4.87 Million
Q2 2017 Aug 11, 2017	BUY	N/A	117,864	117,864 $4.02 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on F Dx Advisors, Inc. with notifications on news.

Account